Aim: The study is to investigate whether diuretic acetazolamide (AZA) protects against renal ischemia-reperfusion (I/R) injury, and its possible link with water channel aquaporin-1 (AQP1). Methods: In vivo study was conducted using AQP1 wild-type (AQP1 +/+ ) and knock-out (AQP1 -/-) mice, randomly divided into three groups: sham, I/R and AZA treatment group. Mice blood was collected for renal function measurement and kidneys were collected for F-actin staining, Western blot examination. In vitro study was examined by HK-2 cell line with hypoxia/ reoxygenation injury. We observed the migration promoting effect of AZA using wound-healing and transwell assays. AQP1 specific siRNA knockdown and overexpression plasmid were also utilized. Aim: To study the quantification methods and pharmacokinetic application of lapachol. Methods: A sensitive and specific high-performance liquid chromatography-tandem mass spectrometry method (LC/ESI/MS) was developed and validated for quantification of the bioactive naphthoquinone lapachol in rat plasma after intragastric administration. The analytes were determined using the negative electrospray ionization mode in the selected reaction ion monitoring (SRM). The chromatographic separation was on a Capcell C 18 column coupled with a C 18 guard column using a mobile phase composed of acetonitrile-water containing 0.02% acetic acid. Simultaneous MS detection of lapachol and the internal standard was performed at the m/z 241 (lapachol) and m/z 255 (Isoliquiritigenin), and the SRM of the two compounds were at 186 (lapachol) and 135 (Isoliquiritigenin), respectively. Results: The lower limit of quantification was 10 ng/mL in rat plasma. The precision measured was obtained from 3.49 to 8.38%. Extraction recoveries were in the range of 84.79%-97.67%. Conclusion: This method was successfully applied to the quantification and pharmacokinetic study of lapachol in rats.
S11.8
Thymoquinone causes endothelium-dependent augmentation depending on activation of soluble guanylyl cyclase in porcine coronary arteries Charlotte M DETREMMERIE 1 , Susan Wai-Sum LEUNG 1 , Aimin XU 1 , Khalid ALKHARFY 2 , S11.9 WS070133 effect on sleep-promoting neurons in the ventrolateral preoptic nucleus Lida DU, Wing-Ho YUNG * . School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China * To whom correspondence should be addressed.
In clinical practice, sedatives are expected to induce the sedation without serious side effects. WS070133 ((3S4R,5R)-3,4-dihydroxy-5-(6-((4-hydroxy-3-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl) methyldecanoate is a new synthesized adenosine derivative. Previous behavioral study show that WS070133 induce sedative effects and sleep promoting effect. This research is concentrated to elucidate the possible effects of WS070133 on the sleep-promoting area in hypothalamus. Whole cell patch clamp-recording was performed to test the WS070133 induced excitation of VLPO neurons by increasing their spontaneous firing thereby in sleep function. The adenosine and its derivatives excite adenosine receptors in the neurons of ventrolateral preoptic nucleus (VLPO), and trigger sleep when excited VLPO neurons release inhibitory neurotransmitters to nearby wakepromoting area. Our results show that WS070133 excited VLPO neurons through a postsynaptic activation of type A 2A adenosine receptors. The firing rate of type 2 VLPO neurons was significantly increased under 10 -5 mol/L WS070133, reveal that the WS070133 induce sleep via the activation of sleep-promoting neurons in VLPO.
The results suggest that the activation of neurons in the ventrolateral preoptic nucleus could be a possible pattern for adenosine derivative WS070133 to induce sedation. Keywords: WS070133; ventrolateral preoptic nucleus; sleep promoting; patch clamp S11.10 Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation Wei-rong FANG, Peng LV, Xiao-han GENG, Er-xin SHANG, Qi-chuan YANG, Lan SHA,
Section 11: CPS-HKPS Young Investigators Awards for PhD Students npg
Yun-man LI * . Department of Physiology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China * To whom correspondence should be addressed.
Aim: Blood brain barrier (BBB) dysfunction is a common facet of cerebral ischemia, and the alteration of drug transporter, P-glycoprotein (P-gp), has been documented. This study explores influence of damaged BBB and elevated P-gp on cerebral verapamil penetration after ischemia both in vivo and in vitro. Methods: Middle cerebral artery occlusion (MCAO) induced ischemia/reperfusion (I/R) of rats, and Na 2 S 2 O 4 induced hypoxia/reoxygenation (H/R) damage of rat brain mirovessel endothelial cells (RBMECs) respectively served as BBB breakdown model in vivo and in vitro. Evans-Blue (EB) extravagation and 125 I-albumin were used to quantify BBB dysfunction; UPLC-MS/MS analytical method was performed to determine accurately the concentration of verapamil in brain tissue and cell. Flow cytometry, immunohistochemisty and Western blotting were applied to evaluate transport function and protein expression of P-gp. Results: Overexpressed ICAM-1 and MMP-9 mediated BBB dysfunction after ischemia, which induced EB leakage and 125 I-albumin uptake increase. Enhanced accumulation of verapamil in brain tissue, but intracellular concentration reduced evidently after H/R injury. Transcellular transportation of verapamil elevated when P-gp function or expression was inhibited after H/R injury. Conclusion: These data indicated that BBB penetration of verapamil under ischemia condition was not only depending on BBB breakdown, but also regulated by P-gp. Keywords: cerebral ischemia; blood brain barrier; P-glycoprotein; verapamil S11.11 Hrd1 facilitates tau degradation by proteasome and lysosome pathways. . However, the underlying mechanism remains unclear. Here, we found that Hrd1 interacted with tau and promoted the degradation of total tau and p-tau as well. The degradation of tau depended on its Hrd1 E3 activity. Knockdown of endogenous Hrd1 with siRNA stabilized tau levels. In addition, inhibition of proteasome maintained tau level and increased Hrd1-mediated tau ubiquitination, suggesting the proteasome was involved in tau/p-tau degradation. Additionally, tau levels were decreased significantly on autophagy induced by rapamycin, which was reversed on inhibition of autophagy by 3-MA or NH4Cl, suggesting tau can be degraded by autophagy. Hrd1 over-expression decreased tau and p-tau levels while inhibition of autophagy activity by 3-MA or NH4Cl stabilized tau, but not p-tau. Moreover, Hrd1 facilitates the formation of autophagosome in tau-overexpressing cells, suggesting Hrd1-mediated tau degradation partly depends on autophagy-lysosome pathway. Furthermore, over-expression of Hrd1 significantly alleviated tau cytotoxicity and promoted cell survival. These results indicated that Hrd1 target tau for proteasome and autophagy degradation and promotes neuron survival. This study provides an important insight into the molecular mechanisms of human tauopathies. Keywords: Alzheimer's disease; tau; tauopathies; Hrd1; ubiquitin-proteasome pathway; autophagy-lysosome pathway S11.12 Pentamethylquercetin (PMQ) inhibited the growth of hepatic ascitic tumor cell H22 by improving metabolic environment in monosodium glumate (MSG)-induced obese mice Wen-qi GAO, Man-wen JIN.
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Aim: Obesity is associated with higher risk and with poor prognosis of cancer. We investigate the effects of PMQ on the metabolic disorders and the tumor growth in MSG-induced obese mice. Methods: MSG-induced obese mice model was established. At 5 week of age, all mice were randomized to ten groups (n=10 per group): Control and MSG model+vehicle, PMQ 5, 10, and 20 mg/kg/d, metformin 300 mg/kg/d respectively and administrated by gastric gavage for 19 weeks. Twenty-two weeks old mice were injection sc with H22 hepatic ascitic tumor cells.
After two weeks, animal were anesthetized and blood, tumor, liver, adipose tissues were harvested. Results: Compared with control mice, MSG treatment induced obesity, metabolic disorders, and much larger tumor in mice. In obese mice, the expression of Sirt6 and PTEN were down-regulated and the expression of TBK1, IKKε and c-Myc were up-regulated. PMQ dose-dependently reduced body weight gain and adipose weight, improved insulin resistance and metabolic disorders, and inhibited tumor growth in MSG mice. There is significant positive correlation between improved metabolism and inhibited tumor growth by chronic PMQ treatment. With treatment of PMQ, the expressions of Sirt6, PTEN, TBK1, IKKε, and c-Myc were totally inversed. E-mail: wanghui19@whu.edu.cn Aim: Metabolic abnormalities were reported in maternal-fetal unit with intrauterine growth retardation (IUGR). Here we aimed to investigate the metabolomes in maternal-fetal biofluid of caffeine-induced IUGR and tried to explore maternal biomarkers. Methods: Pregnant rats were orally treated with caffeine (20, 60, and 180 mg/kg) from gestational days (GD) 11 to 20. Metabolome of maternal and fetal plasma on GD20 and maternal plasma on different times (GD11, GD14, and GD17) were analyzed by 1 H nuclear magnetic resonance-based metabonomics.
Corticosterone (CORT) level in maternal and fetal plasma were determined by ELISA. Results: Caffeine increased maternal and fetal CORT levels which are negatively correlated with fetal bodyweights, respectively. Fetal metabolome were altered by caffeine, which presents as elevated glucose and decreased lactic acid, reduced fatty acids, triglyceride and β-hydroxybutyric acid (BHB), varied apolipoprotein and increased levels of several amino acids. The maternal metabolome indicated decelerated glucose while enhanced lipid metabolism and accelerated protein catabolism while some metabolites had altered since midgestation. Conclusion: IUGR maternal-fetal metabolome was changed by CORT elevation. Maternal CORT level and some metabolites namely α-, β-glucose, highdensity lipoprotein-cholesterol, BHB, isoleucine and valine might be an integrated biomarker system for caffeine-induced IUGR. Keywords: caffeine; IUGR; metabolome; glucocorticoid; biomarkers Acknowledgements: This study was supported by the National Natural Science Founadation of China (No 81220108026 and 81072709).
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Procaspase-3 activator PAC-1 and YCL0426 induce hypoxia reaction and DNA damage in tumor cells Aim: Gentiopicroside-containing extract and gentiopicroside from Gentiana manshurica Kitagawa (GM) was investigated for their hepatoprotective effects in vivo. Methods: We applied in vivo model of acetaminophen (APAP)-induced liver injury, D-galactosamine (GalN)/lipopolysaccharide (LPS)-induced feminant hepatic failure and ethanol-induced acute alcohol liver injury models using C57BL/6 mice. Results: GM significantly prevented the APAP-induced acute hepatotoxicity by enhancing the hepatic antioxidant activity, involving the inhibition of caspase-3 cleavage and JNK/ERK activation. GM prevented ethanol-induced acute liver steatosis, possibly through blocking CYP2E1-mediated free radical scavenging effects and SREBP-1-regulated fatty acid synthesis. And gentiopicroside also protects against GalN/LPS-induced liver injury, which prevents oxidative stress, apoptosis and MAPK phosphorylation. Conclusion: Thus, GM may be useful as a potential pharmacological therapy for the prevention of liver injury and represent a potential new source of drugs for hepatoprotection. Keywords: Gentiana manshurica Kitagawa; feminant hepatic failure; alcohol steatosis Acknowledgements: This study was supported by the National Natural Science Foundation of China (81260664 and 81160538).
S11.22
Anti-proliferative effect of MAM, a natural product on human breast cancer cell MCF-7 by inducing apoptosis through the mitochondria-dependent pathway Aim: Microglia and astrocytes in the brain play an important role in the development and/or progression of Alzheimer's disease (AD). Serum amyloid A (SAA) is a major acute-phase protein produced locally in the brain and colocalized with senile plaques in AD patients. We investigated whether SAA plays a role in the development of AD. Methods: The viability of cultured primary microglia and astrocytes was measured by MTT; cell cycle and apoptosis analysis was also conducted. Cultured microglia and astrocytes were simulated with 1 μmol/L SAA for different periods of time (2, 4, 6, and 12 h) or treated with 1 μmol/L SAA with or without 15 min pretreatment of MAPK or PI3K inhibitors. Total RNA was extracted for qPCR analysis. Results: SAA induced morphological changes of primary microglia but not astrocytes. Interestingly, SAA increased the viability of microglia by inhibiting their apoptosis and reduced the viability of astrocytes by inducing G 1 cell cycle arresting. SAA treatment increased the mRNA levels of IL-6, TNF-α, IL12p40, IL23p19, and IL-10, with higher potency in microglia than in astrocytes. However, SAA induced more iNOS mRNA in astrocytes than in microglia. SAA induced these cytokines and iNOS expression by activating the PI3K pathway in both glial cells, but selectively activated the JNK pathway in microglia and the NF-κB pathway in astroctyes. Conclusion: These results suggest that SAA can stimulate a different reactive phenotype in microglia and astrocytes, and SAA regulates cell viability differently in these two glial cell in part through the PI3K pathway. Keywords: Alzheimer's disease; serum amyloid A; microglia; astrocytes This overview is to comprehensively understand the role of telomerase in neuronal stem cell (NSC). We reviewed the papers concerning about the function of telomerase in the self-renew, proliferation, differentiation, survival and fatedecision of embryonic and adult NSC. It is revealed that telomerase is essential for the ability of self-renew and proliferation of NSC. Moreover, telomerase promote the ability of neuronal differentiation of NSC. Importantly, telomerase also exists in the new born neurons and play a critical role in the morphological and functional maturation. Telomerase also can protect neurons from apoptosis and excitoxicity and promote survival. Increasing data suggest that adult hippocampal telomerase involves in the modulation of depression-related behaviors by regulating hippcampal neurogenesis. Understanding the role of telomerase in NSC is not only important for gaining further insight into the mystery of NSC, but also helpful for searching a novel therapeutic target for the treatment of depression and other neurodegenerative diseases. Keywords: telomerase; neuronal stem cell Acknowledgements: This work was supported by the National Natural Science Foundation of China (81000586). Aim: Glucagon-like peptide-1 (GLP-1) attracts interest for notable benefits in T2DM patients, but the short half-life limits its clinical use. Anti-enzymatic and oral cyclic GLP-1 analogues were biosynthesized, and in vitro and in vivo bioactivity was evaluated. Methods: The inhibitory domains of DPP-IV and/or neutral endopeptidase 24.11 (NEP24.11) were introduced in glp-1. The fusion protein containing hGLP-1-Mxe GyrA intein-CBD (C-terminal binding domain) was induced to express in E coli BL21 (DE3), and purified by affinity chromatography on chitin beads and on-column splicing by induction of 2-mercapto ethanesulfonic acid (MESNA) at pH 8.5. The anti-enzymatic and GLP-1 receptor agonistic activities were tested. The hypoglycemic effects were investigated in ICR mice. Results: Three series of peptides named 61, 31C and 31 were gotten, and each contains linear or cyclic molecular structures. The analysis of RP-HPLC showed that the residual area of 61N 2 incubated with DPP-IV for 24 h was 49.9%, and those of 31CK and 31K incubated with NEP24.11 for 4 h were nearly 50% and 20%, respectively. 61K, 31CK and 31K could significantly increase the GLP-1R specific luciferase reporter gene expression transfected in NIT-1 cells from 0. E-mail: liqw@263.net (Qing-wei LI); lv_li@126.com (Li LV) Aim: The aim of this paper is to investigate the protective effects of recombinant Lampetra Japonica RGD-peptide (rLj-RGD3) on PC12 cells oxygen-glucose deprivation and reperfusion (OGD/RF) injury, and discuss the protection mechanism. Methods: Normal cultured PC12 cells were randomly assigned to 6 groups: normal cell control group, model group, rLj-RGD3 high (25 μg/mL), medium (12.5 μg/mL) and low (6.25 μg/mL) groups and Edaravone positive control group (4 μg/mL). By using DMEM medium containing deoxidation agent (Sodium dithionite Na 2 S 2 O 4 ) merged deficiency sugar, PC12 cells were incubated for 2 h under oxygen-glucose deprivation and refperfusion for 24 h. Cell vitality, Lactate dehydrogenase (LDH) activity in cell supernatant fluid and glutathione (GSH) concentration in cell were measured after 24 h. Cell apoptosis situation was observed by AO/EB fluorescence color and Annexin V-PI flow cell technology. The protein expression levels of FAK, p-FAK, Caspase-3, Bcl-2 were detected by the Western blotting method. Results: The cell vitality of the model group was markedly decreased after OGD/RF. The activity of LDH in cell supernatant fluid was increased significantly and the content of GSH in cell was reduced significantly. In rLj-RGD3 administration group the cell vitality and the content of GSH were significantly increased. The activity of LDH in cell supernatant fluid decreased obviously and had certain dose dependence. The model group increased cell apoptosis significantly by the AO/EB dyeing and flow cytometry detection technology. By contrast, cells apoptosis was significantly reduced in rLj-RGD3 O-acetonitrile (40:60, v/v) . Nitrendipine was used as an internal standard (IS). The retention times of QO58-lysin and the IS in rat plasma were 3.8 and 5.4 min, respectively. Calibration curve was linear ranging from 0.1 to 120 μg/mL with a correlation coefficient (r 2 ) of 0.9996. The lower limit of quantification was 0.1 μg/mL. Accuracy, precision, recovery and stability were all within acceptable criteria according to FDA guidelines. The validated assay was successfully applied to determine the pharmacokinetics of QO58-lysin administered intravenously (10 mg/kg) and orally (12.5, 25, and 50 mg/kg) in SD rats. Keywords: KCNQ opener; QO58-lysin; HPLC; pharmacokinetics S11.31 Endoplasmic reticulum stress aggravation as the mechanism underlying Guttiferone K-induced apoptosis in colorectal cancer cell line HCT116 Chinese Medicine, Shanghai, China Aim: Guttiferone K (GutK) is a novel cytotoxic compound able to selectively induce apoptosis in colorectal cancer cells. The study proposes endoplasmic reticulum (ER) stress aggravation as the underlying mechanism of action in GutK-induced apoptosis and suggests such mechanism as the rationale of its cancer selectivity. Methods: Treatment of various concentrations of GutK with or without specific inhibitor for JNK SP600125 and subsequent GutK treatment for 24 h with or without pre-treatment of chemical chaperone 4-PBA in colon cell line HCT116 confirmed that GutK acts through ER stress-induced apoptotic pathways.
S11.24 Adult hippocampal telomerase is implicated in mood disorders

S11.26
Immunoblotting of PARP cleavage and annexin-V flow cytometry were adopted to probe propensity to apoptosis whereby real-time PCR and immunoblotting were adopted to identify changes in ER stress marker CHOP and GRP78 protein and gene expression, respectively. Results: SP600125 markedly blocked GutK-induced apoptosis in HCT116. GutK induced up-regulation of CHOP and GRP78 in mRNA and protein expression in a dose-dependent manner. 4-PBA effectively reverted GutK-induced apoptosis. Conclusion: The study confirmed ER stress aggravation as the underlying mechanism of action in GutK-induced apoptosis and suggested that such mechanism might be one of the reasons for its cancer selectivity. Lipocalin-2 is a glycoprotein constitutively secreted by adipocytes. In obese human subjects, the circulating lipocalin-2 level is elevated and positively correlated with systolic arterial blood pressure, dyslipidemia and insulin resistance. In mice, deficiency of lipocalin-2 protects against aging-and obesity-induced endothelial dysfunction. High pressure liquid chromatography combined with enzymelinked immunosorbent analysis revealed that the 20-HETE content was upregulatedsignificantly in the aorta of lipocalin-2 knockout mice, whereas the amount of 11,12-diHETE decreased in the same tissues. Incubation with 20-HETE (10 -7 mol/L) significantly attenuated the contractions induced by the TP receptor agonist U46619 in aortic rings and by acetylcholine in carotid arteries. In summary, increased production of 20-HETE contributes to the improved endothelial function in lipocalin-2 deficient mice. Keywords: lipocalin-2; 20-HETE; endothelial dysfunction
S11.36
Measuring emotional and non-emotional behaviours in mice: a triple integrated test In this study, we set up six groups: control group: the normal culture HUVECS; ox-LDL group: HUVECs were incubated with 20 μg/mL h ox-LDL for 24 h; low concentration OA group: HUVEC were pretreated with 5 μmol/L OA for 0.5 h, then as same as ox-LDL group; middle concentration OA group: HUVEC were pretreated with 10 μmol/L OA for 0.5 h, then as same as ox-LDL group; high concentration OA group: HUVEC were pretreated with 20 μmol/L OA for 0.5 h, then as same as ox-LDL group; vitamin E group: HUVEC were pretreated with 200 μmol/L VE for 0.5 h, then as same as ox-LDL group. LOX-1 and NADPH oxidase subunits p22phox, p47phox mRNA expression levels were evaluated by RT-PCR. LOX-1 and NADPH oxidase subunit gp91phox protein expression levels were evaluated by Western blotting. ESR was used to determine the time dependent release of NO and ROS, as well as the effect of ox-LDL, OA and VE on the release of NO and ROS. To generate LOX-1-siRNA-expressing plasmids, then use lipefectime TM 2000 method to transfect into HUVEC. The transfection rate was measured using flow cytometry and cell viability was measured by MTT assay. We set up four groups: control group; ox-LDL group; LOX-1-siRNA and ox-LDL group; and pCon group. Analysis LOX-1, P47phox and gp91phox expression of the above four groups. Results: The results show that treating with 20 μg/mL h ox-LDL increased the viability of HUVEC, while OA could converse the effect. Ox-LDL increased LOX-1, P47phox, gp91phox expression. But ox-LDL had no influence on P22phox expression. OA raised the cell survival rate obviously in a dose-dependent manner. OA down regulated LOX-1 mRNA and p47phox mRNA expression. Expressions of LOX-1 and gp91phox protein were regulated down by OA. Compared with ox-LDL group, pre-treating with different concentrations of OA groups and VE group down regulated LOX-1, p47phox and gp91phox expression, released less of both NO and ROS. In comparison, LOX-1-siRNA and ox-LDL group had less LOX-1, P47phox and gp91phox expression and less release of NO and ROS. Conclusion: Oleanolic acid has protective effect on HUVECs against injury induced by ox-LDL. The mechanism of its protective effect is to inhibit the signal pathway LOX-1/NADPH/ ROS. Keywords: oleanolic acid; LOX-1; NADPH oxidase; oxidized low density lipoprotein; HUVEC S11.40 Novel hydrogen sulfide releasing derivatives of 3-n-Butylphthalide attenuate ischemic brain damage induced by transient middle cerebral artery occlusion in rats via inhibition of NOX4 Lin-na WANG, Ting-ting LI, Hui JI. Department of Pharmacology, China Pharmaceutical University, Nanjing 210009, China Aim: NBP was employed as the lead compound to obtain a novel class of H 2 Sreleasing derivatives. We investigated their antiplatelet activity in vitro and antiischemic stroke activity in vivo, and addressed the mechanisms that contributed to the neuroprotective effects. Methods: The effects of target compounds on adenosine diphosphate (ADP)-induced platelet aggregation were assayed using Born's turbidimetric method. Data were calculated and expressed as the IC 50 values. We also examined the protective effects of the most potent compound I-a on cerebral ischemia induced by middle cerebral artery occlusion (MCAO). At 24 h post MCAO, neurological deficit and infarct size of brain were evaluated, NADPH oxidase (NOX) 4 protein expression in brain were determined by Western blotting.
Results: The IC 50 value of I-a (0.19 mmol/L) on ADP-induced platelet aggregation was 3.8-and 1.9-fold less than that of NBP (0.73 mmol/L) and Ticlopidine (0.36 mmol/L). And the pretreatment of I-a reversed the elevation of neurological deficit score and brain infarct size caused by cerebral ischemia. I-a treated groups obviously reduced the infarct size to 13.22% (193 mg/kg) and 19.17% (80 mg/kg) (P<0.001 vs vehicle group). Additionally, the increase of Nox4 protein expression after MCAO was attenuated by I-a. Conclusion: Our findings suggest that I-a may be a promising agent against cerebral ischemic injury via inhibition of NOX4 in brain.
Keywords: 3-n-butylphthalide derivative; antiplatelet activity; cerebral ischemia; MCAO; NOX4
S11.41
High level expression of anti-TNF-α monoclonal antibody in CHO/DHFR -cells E-mail: luoxuegang@tust.edu.cn (Xue-gang LUO); tony@tust.edu.cn (Tong-cun ZHANG) Aim: TNF-α has been proved as a therapeutic target for rheumatoid arthritis. However, the cost of anti-TNF-α biologic agents is considerable and unacceptable at present. Here, a high level expression system of anti-TNF-α monoclonal antibody (mcAb) was constructed in dihydrofolate reductase-negative Chinese hamster ovary (CHO/DHFR -) cells. Methods: The gene encoding LC and HC with the kozak sequence in the start codon was optimized for CHO cells, and an internal ribosome entry site (IRES) was linked between LC and HC. The fused LC-IRES-HC gene was then inserted into expression vector pcDNA3.1(+) and the selectable markers neomycin resistance gene (Neo r ) of the vector was replaced by DHFR gene. The recombinant plasmid was linearized and transfected into CHO/ DHFR -cells. The plasmid was stepwise amplified by 0, 10, 20, 50, 100, 200, 500, and 800 nmol/L methotrexate (MTX) for 5-6 months. Stably transfected cells were selected, and then cloned using the limiting dilution method. The extraneous DNA integrated into the genomic DNA was detected by PCR, the transcription of LC or HC was examined by RT-PCR, and the production of anti-TNF-α mcAb in cellular supernatant was quantified using ELISA assay. Aim: Pseudoginsenoside-F11 (PF11), an ocotillol-type ginsenoside isolated from leaves of Panax quinquefolium (American ginseng), has been shown to improve the scopolamine-induced memory impairments in mice and possess significant neuroprotective activity in APP/PS1 mice. Although PF11 plays a lot of beneficial effects on disorders of the central nervous system (CNS), its cellular mechanism in microglia is unknown. In the present study, we assessed the antiinflammatory effect of PF11 on the production of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated N9 microglia. Methods: The expressions of iNOS, TNF-α, IL-6, and IL-1β in LPS-stimulated N9 microglial cells were determined by Western blotting and/or RT-PCR, respectively. NF-κB activation was investigated by High-Content assay and Western blotting. Results: PF11 suppressed production of nitric oxide (NO), prostaglandin E 2 (PGE 2 ) and the proinflammatory cytokines, interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumour necrosis factor-α (TNF-α) in a concentration dependent manner. In addition, PF11 down-regulated the TLR4 protein expression, resulted in inhibiting NF-κB-dependent inflammatory responses by modulating a series of intracellular events of TAK1-IKK-IκBa-NF-κB signaling in N9 microglial cells. Moreover, PF11 inhibited Akt and MAPK signaling pathways. Importantly, PF11 significantly alleviated the death SH-SY5Y neuroblastoma cells, rat primary cortical and hippocampal neurons induced by the conditioned-medium from activated microglia. Conclusion: PF11 downregulated inflammatory iNOS, COX-2, TNF-α, IL-6, and IL-1β genes and proteins expression in N9 microglia interfering with the upregulation of TLR4, activation of NF-κB, MAPKs, and Akt pathways, thus, preventing neuron cells death. PF11 is a promising candidate for the development of neuroprotective drugs. Keywords: PF11; microglia; inflammation; NF-κB; MAPK Acknowledgements: This work was supported by the National Natural Science Foundation of China (30973890) and by the National Key Scientific Project for New Drug Discovery and Development, China (2010ZX09401-304).
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Chaperone heat shock protein 70 modulators dual-regulate the development of behavioral sensitization induced by a single morphine exposure in rats Yan-ting WANG, Jian-hui LIANG * . National Institute on Drug Dependence, Peking University, Beijing 100191, China * To whom correspondence should be addressed.
E-mail: liangjh@bjmu.edu.cn Aim: Our previous studies have revealed behavioral sensitization, closely relating to drug addiction, mediated by chaperone heat shock protein 70 (Hsp70) in mice. This study aimed to investigate the effects of chaperone modulators on behavioral sensitization and Hsp70 in Nucleus Accumbens (NAc) core in rats. Methods: Rats received a single dose of morphine (1-10 mg/kg, sc) to induce a longterm behavioral sensitization. The time-and dose-effect of morphine on Hsp70 expression were detected by Western blot. Chaperone modulators including the inhibitors KNK437, methylene blue (MB), pifithrin-μ (PES), and inducer geranylgeranylacetone (GGA) were used to modulate Hsp70 and behavioral sensitization. Results: Morphine (3 and 10 mg/kg) could not only induce behavioral sensitization, but also increase Hsp70 expression in NAc core of rats. Pearson analysis indicated a significant positive correlation between magnitudes of behavioral sensitization and levels of Hsp70 expression (r=0.997). Intra-NAc core microinjection of KNK437 (2-10 μg/rat) attenuated Hsp70 expression and behavioral sensitization, while GGA (20-80 μg/rat) promoted them. Functionally, MB (10-90 μg/rat) and PES (1-4 μg/rat) impaired the development of behavioral sensitization. It is a risk which usually accompany with the normal drug therapy. Adverse drug reactions monitoring is not only a very important content of drug post-marketing studies but also a kind of effective method to strengthen the post-marketing drug safety regulation and to ensure a safe and effective human medication. In our country, spontaneous reporting system (SRS) is used for monitoring of adverse drug reactions, which is the most important measures for adverse drug reaction monitoring all over the world. In the implementation of spontaneous reporting system, those self-reported ADR reports is the main source for discovering the new adverse drug reactions signals of post-marketing drugs. This study is going to develop a practical software package including data collecting function, data processing function and monitoring & warning function, in order to achieve the automation of the ADR data extraction and adverse drug reaction signal detection and make data pre-processing faster and more convenient. Aim: Long acting luteinizing hormone-releasing hormone (LHRH) antagonists designed to be protease-resistant were a series of novel decapeptides structurally similar to LHRH. In this study, a high-throughput method based on a LC-MS/ MS has been developed for the simultaneous determination of pharmacokinetics of five LHRH antagonists in rat via cassette dosing. Methods: The method was performed under selected reaction monitoring (SRM) in the positive ion mode. The analytes were extracted from 50 μL rat plasma by liquid-liquid extraction with acetonitrile. Chromatographic separation of the analytes was successfully achieved on a Hypersil column using a mobile phase composed of acetonitrile water (30:70) containing 0.1% (v/v) formic acid. Results: The result showed good linearity and selectivity were obtained for all antagonists. The limits of quantification of the five LHRH antagonists were from 5 to 10 ng/mL. The average extract recoveries in the rat plasma were all over 72%. The intra-day and inter-day precisions (RSD%) were all within 10% and the accuracy was ranged from 92.54 to 109.05%. This method has been successfully applied to the pharmacokinetic studies of the five LHRH antagonists. The results indicated that the plasma drug concentration versus time curves after intravenous injection of these five antagonists via cassette dosing was all fitted to a two-compartment model. The results provided abundant information on the metabolic properties of the five novel LHRH antagonists. Conclusion: Based on the in vivo and in vitro stabilities of these peptides, it was concluded that LY616 and LY 608 could be the more stable candidate drug. 
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Rats exposed to traumatic stress wake up with a start afterwards during deep sleep: implications for uncovering PTSD nightmare Bin YU, Xiang-yu CUI, Su-ying CUI, Juan ZHANG, Zi-jun WANG, Zhao-fu SHENG, Xueqiong ZHANG, Sheng-jie LI, Li-yuan HUANG, Qing CAO, Ya-ping XU, Zhi-ge LIN, Yonghe ZHANG * . Department of Pharmacology, Peking University, School of Basic Medical Science, Beijing 100191, China. * To whom correspondence should be addressed. E-mail: yhzhpku@hsc.pku.edu.cn Aim: Posttraumatic nightmares are a prevalent and distressing symptom of posttraumatic stress disorder (PTSD). In this study, we found some rats wake up with a start after traumatic stress and investigated the underlying neuroanatomical pathway of this behavior. Methods: Female SD rats exposed to inescapable footshock in proestrous. Twenty-one days after the shock, rats were used for observing whether wake up with a start by using infrared camera and recording EEG/EMG simultaneously. The activation of brain regions was evaluated via the level of c-Fos expression. All results were compared with normal awakening. Results: EEG delta power density was significantly increased in one-minute sleep prior to awake with a start, which suggested that the startle awakening was happened during deep sleep. Among the sleep/wake regulating nuclei the results showed that c-Fos expression decreased in orexinergic neurons of perifornical nucleus (PeF), and increased in noradrenergic neurons of locus coeruleus (LC). In addition, c-Fos expression of fear emotion regulating regions was decreased in infralimbic cortex (IL), and increased in both basolateral and central amygdala.
Conclusion:
These results indicate that rats exposed to trauma wake up with a Section 11: CPS-HKPS Young Investigators Awards for PhD Students npg mediated protection against LPS-induced DA neurodegeneration was evaluated. Methods: For in vivo studies, stereotaxic injection of LPS into rat SN was used to investigate TSG-mediated neuroprotection. For in vitro studies, rat primary midbrain neuron-glia co-cultures were applied to explore the mechanisms underlying this neuroprotection. Results: TSG protected DA neurons against LPS-induced neurotoxicity. In vitro studies revealed microglia were responsible for TSG-mediated neuroprotection and this effect was mediated by 1) inhibiting microglial activation and subsequent production of various pro-inflammatory factors, 2) suppressing NADPH oxidase activity and further decreasing reactive oxygen species (ROS) production, and 3) attenuating NF-κB cascade signaling pathways activation. Conclusion: TSG produces protection against LPS-induced DA neurodegeneration and might be of potential benefit for PD. Keywords: Parkinson disease; neuroinflammation; microglial activation; tetra hydroxystilbene glucoside; neuroprotectionS11.54 miRNA mimics -a novel approach for gene-specific interference of nicotine induced atrial fibrosis Yong ZHANG, Hong-li SHAN, Wen-feng CHU, Xi CHEN, Yan-jie LU, Bao-feng YANG.
Department of Pharmacology, the State-Province Key Laboratories of BiomedicinePharmaceutics of China, Key Laboratory of Cardiovascular Research, Harbin Medical University, Harbin 150081, China
Aim: This present study was designed to decipher molecular mechanisms underlying nicotine's promoting atrial fibrillation (AF) by inducing atrial structural remodeling (ASR) after cigarette smoking/nicotine exposure. Methods: The rat model of AF was established by nicotine administration. Luciferase was used to detect the regulation of miR-133 on TGF-β1 and CTGF. The role of miRNAs on the expression and regulation of CTGF, TGF-β1 and collagen production was evaluated in vivo and in vitro. Results: The rats treated with nicotine were more prone to AF induction in response to a premature extrastimulus following a train of rapid pacing. Collagen content was significantly higher with treatment of nicotine. Western blot analysis revealed significant upregulation of CTGF and TGF-β1 genes at the protein level in nicotine-treated atrial fibroblasts. miR-133 was significantly downregulated in the presence of nicotine in rat atrial fibroblasts. Transfection of miR-133 into the cultured atrial fibroblasts remarkably reduced the protein level of CTGF and TGF-β1, and co-transfection of AMO-133 abolished the effect. Transfection of the synthesized miRNA mimics (miR-CTGF) significantly diminished collagen content and the effects were antagonized by their respective AMOs. Conclusion: Downregulation of miR-133 by nicotine triggers generation of atrial fibrosis and fibrillation via removal of post-transcriptional repression of CTGF and TGF-β1 and consequent production of collagens. Keywords: nicotine; atrial fibosis; CTGF; miR-133; miRNA mimics Acknowledgements: This study was supported by the National Natural Science Foundation of China (30901208 and 81270042).
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Changes in genes expression and aberrant promoter methylation during polypeptide from Chlamys farreri inhibits the transformation of human HaCaT keratinocytes induced by UVB irradiation Hui-hui ZHAO, Chun-bo WANG. Department of Pharmacology, Medical College, Qingdao University, Qingdao 266021, China Aim: To establish a model that human HaCaT keratinocytes is transformed by multiple doses of UVB and investigate the mechanism of polypeptide from chlamys farreri (PCF) can inhibite the transformation of HaCaT cell induced by UVB irradiation. Methods: Human HaCaT keratinocytes were devided into four groups: control group, UVB model group, UVB+2.84 mmol/L vitamin C positivecontrol group, UVB+2.84 mmol/L PCF group. Confluent layes of human HaCaT keratinocytes grown in a culture dish were exposed to UVB (15 mJ/cm 2 ). Our study was to evaluate the effect of two sorts of p38 MAPK inhibitor SB203580 and BIRB796 on protection of SM-induced skin injure. Methods: SB203580 and BIRB796 were administered intraperitoneal injection to the SM-induced mouse ear vesicant model 24 h, 30 min before and during 12 h SM period. Ear edema was detected at different time points after SM challenge. To examine the impact of SB203580 and BIRB796 on activation of MAPK on SM-induced injury model, the phosphorylation of p38 and c-jun-Nterminal kinase (JNK) were analyzed with Luminex assay in immortalized nontumorigenic human keratinocytes cells HaCaT. Results: On SM-induced mouse ear vesicant model, BIRB796 was shown to reduce approximate 17% ear edema at 24 h and 48 h after SM challenge. While SB203580 had marginal effect on ear edema. In vitro study revealed that compared to SM-challenged controls, the levels of p-p38 and p-JNK were both decreased significantly by BIRB796, whereas only p-p38 decreased by SB203580. Interestingly, p-JNK increased modestly by SB203580. Conclusion: In our study, p38 inhibitor BIRB796 could alleviate SM-induced skin injure, which might concerned with suppressing the activation of p38 and JNK simultaneously. SB203580 had little effect on SM-induced skin injury. It might due to the compensatory activation of JNK. The post-translational modifications of histone, eg methylation and demythalation, regulate chromatin structure as well as gene activation and repression. Lysinespecific demythelase 1 (LSD1), the first identified histone demythalase since 2004, has been reported to be up-regulated in numbers of cancers, including gastric cancer. Targeting LSD1 by specific inhibitors has shown to be a potential strategy to prevent cancer. Here, we generated and screened a series of novel 1, 2, 3-triazole-dithiocarbamate hybrids, which can specifically inhibit the LSD1 activity with IC 50 less than 10 µmol/L. Interestingly, these LSD1 inhibitors exhibit FAD competitive, with selective and potent cytotoxicity against human gastric cancer cell line MGC-803, while they do not show any toxic effects on several normal cell lines. In addition, in vitro study suggested that in MGC-803 cells, the cell cycle was arrested and cell apoptosis was induced by these inhibitors. On the other hand, the cell migration and invasion were also markedly inhibited. Our findings indicate that these LSD1 inhibitors may be potential candidates to target gastric cancer cells. Keywords: LSD1; inhibitor; epigenetics; gastric cancer
